Acadia Pharmaceuticals | ACAD - 판매 수익





매상 변화 날짜
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
ALKERMES USD 496.01M 103.1M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Biogen USD 2.74B 490M 2026-06
BioMarin Pharmaceutical USD 766M 109M 2026-03
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Cara Therapeutics USD 2.57M 1.11M 2025-03
Corcept Therapeutics USD 256.15M 91.25M 2026-06
Cytokinetics USD 19.35M 1.59M 2026-03
Eisai JPY 234.33B 28.9B 2026-06
Eli Lilly USD 19.8B 500M 2026-03
Incyte USD 1.67B 400M 2026-06
J&J USD 25.31B 1.21B 2026-06
Moderna USD 100M 289M 2026-06
Neurocrine Biosciences USD 959M 148M 2026-06
Pfizer USD 14.5B 3.08B 2026-03
Prothena USD 51.08M 51.06M 2026-03
PTC Therapeutics USD 361M 88M 2026-06
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Vertex Pharmaceuticals USD 2.99B 200M 2026-03